Per Lindner
-
Molecular profiling of driver events in metastatic uveal
melanoma
Joakim Karlsson, Lisa M Nilsson, Suman Mitra, Samuel Alsén, Ganesh V Shelke, Vasu R. Sah, Elin Forsberg, Ulrika Stierner, C. All-Eriksson, Berglind Osk Einarsdottir, Henrik Jespersen, Lars Ny, Per Lindnér, Erik Larsson, Roger Olofsson Bagge, Jonas A Nilsson
Nature Communications - 2020-01-01 -
Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit
metastasis
Junko Johansson, Roberta Kiffin, Ebru Aydin, Malin S. Nilsson, Kristoffer Hellstrand, Per Lindnér, Peter Naredi, Roger Olofsson Bagge, Anna Martner
Oncoimmunology - 2020-01-01 -
The impact of increased immigration to Sweden on the incidence and treatment of patients with HCC and underlying liver
disease
Helena Taflin, Lars-Olof Hafström, Erik Holmberg, Maria Castedal, Per Lindnér
Scandinavian Journal of Gastroenterology - 2019-01-01 -
A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver
transplantation
Malin Sternby Eilard, Mats Andersson, Peter Naredi, Charalampos Geronymakis, Per Lindnér, Christian Cahlin, William Bennet, Magnus Rizell
BMC Cancer - 2019-01-01 -
Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma
Patients
Junko Johansson, Roberta Kiffin, Annica Andersson, Per Lindnér, Peter Naredi, Roger Olofsson Bagge, Anna Martner
Frontiers in Oncology - 2018-01-01 -
Gallbladder cancer - no improvement in survival over time in a Swedish
population
Per Lindnér, Erik Holmberg, Lars-Olof Hafström
Acta Oncologica - 2018-01-01 -
The risk of graft loss 5 years after kidney transplantation is increased if cold ischemia time exceeds 14
hours
Josefin Hansson, Lars Mjörnstedt, Per Lindnér
Clinical Transplantation - 2018-01-01 -
Staging and therapy for patients with hepatocellular cancer in a defined population from 2000 to 2011 - active palliative treatment improved overall
survival.
Per Lindnér, Erik Holmberg, Magnus Rizell, Larsolof Hafström
Acta oncologica (Stockholm, Sweden) - 2016-01-01 -
Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic
Perfusion.
Ilan Ben-Shabat, Valerio Belgrano, Lars Ny, Jonas A Nilsson, Per Lindnér, Roger Olofsson Bagge
Annals of surgical oncology - 2016-01-01 -
Erratum to: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled
trial.
Roger Olofsson Bagge, Lars Ny, Charlotta All-Ericsson, Malin Sternby Eilard, Magnus Rizell, Christian Cahlin, Ulrika Stierner, Ulf Lönn, Johan Hansson, Ingrid Ljuslinder, Lotta Lundgren, Gustav Ullenhag, Jens Folke Kiilgaard, Jonas A Nilsson, Per Lindnér
Trials - 2015-01-01 -
The impact of changed strategies for patients with cholangiocarcinoma in this
millenium.
Per Lindnér, Magnus Rizell, Lo Hafström
HPB surgery : a world journal of hepatic, pancreatic and biliary surgery - 2015-01-01 -
Isolated hepatic perfusion as a treatment for liver metastases of uveal
melanoma.
Ilan Ben-Shabat, Christoffer Hansson, Malin Sternby Eilard, Christian Cahlin, Magnus Rizell, Per Lindnér, Jan Mattsson, Roger Olofsson Bagge
Journal of visualized experiments : JoVE - 2015-01-01 -
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled
trial.
Roger Olofsson, Lars Ny, Malin Sternby Eilard, Magnus Rizell, Christian Cahlin, Ulrika Stierner, Ulf Lönn, Johan Hansson, Ingrid Ljuslinder, Lotta Lundgren, Gustav Ullenhag, Jens Folke Kiilgaard, Jonas A Nilsson, Per Lindnér
Trials - 2014-01-01 -
Isolated Hepatic Perfusion for Ocular Melanoma Metastasis: Registry Data Suggests a Survival
Benefit.
Roger Olofsson, Christian Cahlin, C All-Ericsson, Farida Hashimi, Jan Mattsson, Magnus Rizell, Per Lindnér
Annals of surgical oncology - 2014-01-01 -
MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal
melanoma
Maria Eldh, Roger Olofsson Bagge, Cecilia Lässer, Joar Svanvik, Margareta Sjöstrand, Jan Mattsson, Per Lindnér, Dong-Sic Choi, Yong Song Gho, Jan Lötvall
BMC Cancer - 2014-01-01 -
An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after
transplantation.
Jana Ekberg, Henrik Ekberg, Bente Jespersen, Ragnar Källen, Karin Skov, Michael Olausson, Lars Mjörnstedt, Per Lindnér
Transplantation research - 2014-01-01 -
Melan-A specific CD8+ T lymphocytes after hyperthermic isolated limb perfusion: A pilot study in patients with in-transit metastases of malignant
melanoma.
Roger Olofsson, Erika Lindberg, Alex Karlsson-Parra, Per Lindnér, Jan Mattsson, Bengt Andersson
International Journal of Hyperthermia - 2013-01-01 -
Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant
melanoma.
Roger Olofsson, Jan Mattsson, Per Lindnér
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group - 2013-01-01 -
Long-Term Outcome of Isolated Limb Perfusion in Advanced Soft Tissue Sarcoma of the
Extremity.
Peter Bergh, Örjan Berlin, Katarina Engström, Björn Gunterberg, Malin Hansson, Per Lindnér, Jan Mattsson, Roger Olofsson
Annals of surgical oncology - 2012-01-01 -
Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular
cancer.
Magnus Rizell, Mats Andersson, Christian Cahlin, Lars-Olof Hafström, Michael Olausson, Per Lindnér
International journal of clinical oncology / Japan Society of Clinical Oncology - 2008-01-01 -
Isolated hepatic perfusion for liver metastases of malignant
melanoma.
Magnus Rizell, Jan Mattson, Christian Cahlin, Lars-Olof Hafström, Per Lindnér, Michael Olausson
Melanoma research - 2008-01-01 -
Retransplantation of the
liver.
Bengt I. Gustafsson, Lars Bäckman, Styrbjörn Friman, Gustaf Herlenius, Per Lindnér, Lars Mjörnstedt, Michael Olausson
Transplantation proceedings - 2006-01-01 -
Extended right-sided liver resection for colorectal liver metastases--impact of percutaneous portal venous
embolisation
Per Lindnér, Christian Cahlin, Styrbjörn Friman, Lars-Olof Hafström, H. Klingenstierna, Lars Lönn, Michael Olausson, M. Rizell
European journal of surgical oncology - 2006-01-01 -
Blood flow in liver tumors--effects of vasoactive drugs estimated with xenon (133Xe)
clearance.
Per Lindnér, J Tölli, Peter Naredi, M Oman, Lars-Olof Hafström
Hepato-gastroenterology - 2004-01-01 -
A comparison between hepatic artery ligation and portal 5-Fu infusion versus 5-Fu intra arterial infusion for colorectal liver
metastases.
Peter Naredi, M Oman, P-J Blind, Per Lindnér, Bengt Gustavsson, Lars-Olof Hafström
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 2003-01-01 -
Monotherapy with histamine dihydrochloride suppresses in vivo growth of a rat sarcoma in liver and
subcutis.
Magnus Rizell, Kristoffer Hellstrand, Per Lindnér, Peter Naredi
Anticancer research - 2002-01-01 -
P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver
resection.
Y Yang, Ann Forslund, H Remotti, Christina Lönnroth, M Andersson, Hans Brevinge, Elisabeth Svanberg, Per Lindnér, Lars-Olof Hafström, Peter Naredi, Kent Lundholm
Cancer - 2001-01-01 -
Alleviating oxidative stress in cancer immunotherapy: a role for
histamine?
Kristoffer Hellstrand, Mats Brune, Claes Dahlgren, Markus Hansson, Svante Hermodsson, Per Lindnér, Ulf-Henrik Mellqvist, Peter Naredi
Medical oncology (Northwood, London, England) - 2000-01-01 -
Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and
melphalan.
Per Lindnér, M Fjälling, Lars-Olof Hafström, H Kierulff-Nielsen, J Mattsson, Tore Scherstén, Magnus Rizell, Peter Naredi
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 1999-01-01 -
Treatment of primary liver
cancer.
Lars-Olof Hafström, Peter Naredi, Per Lindnér, Stig B Holmberg, Tore Scherstén
The European journal of surgery = Acta chirurgica - 1998-01-01 -
Digitonin enhances the efficacy of carboplatin in liver tumour after intra-arterial
administration.
Per Lindnér, D Heath, S B Howell, Peter Naredi, Lars-Olof Hafström
Cancer chemotherapy and pharmacology - 1997-01-01 -
The influence of zymosan and indomethacin on liver and kidney tumor growth. An experimental study in
rats.
M G Ohman, P Blind, Stig B Holmberg, Peter Naredi, Per Lindnér, Lars-Olof Hafström
Journal of experimental & clinical cancer research : CR - 1997-01-01 -
Vasopressin modulation of peritoneal, lymphatic, and plasma drug exposure following intraperitoneal
administration.
Per Lindnér, D Heath, S Howell, Peter Naredi, Lars-Olof Hafström
Clinical cancer research : an official journal of the American Association for Cancer Research - 1996-01-01 -
Influence of zymosan (a non-specific macrophage stimulator) and of indomethacin on liver tumours--an experimental study in
rats.
Stig B Holmberg, Peter Naredi, Per Lindnér, Ingvar Karlberg, Peter Daneryd, Lilian M. Karlsson, Anders Pettersson, U Stenram, Lars-Olof Hafström
Journal of cancer research and clinical oncology - 1995-01-01 -
Influence of hepatic artery occlusion and desferrioxamine on liver-tumour
growth.
Per Lindnér, Peter Naredi, A Peterson, Lars-Olof Hafström
International journal of cancer. Journal international du cancer - 1995-01-01 -
Isolated hyperthermic liver perfusion with chemotherapy for liver
malignancy.
Lars-Olof Hafström, Stig B Holmberg, Peter Naredi, Per Lindnér, Anders Bengtsson, G Tidebrant, Tore Scherstén
Surgical oncology - 1994-01-01 -
Histamine in immunotherapy of advanced melanoma: a pilot
study.
Kristoffer Hellstrand, Peter Naredi, Per Lindnér, Kent Lundholm, Carl-Magnus Rudenstam, Svante Hermodsson, Mats Asztely, Lars-Olof Hafström
Cancer immunology, immunotherapy : CII - 1994-01-01 -
Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the
liver.
Per Lindnér, G Carlsson, Bengt Gustavsson, Stig B Holmberg, Peter Naredi, A Peterson, Lars-Olof Hafström
Anticancer research - 1994-01-01 -
Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical
trial.
Lars-Olof Hafström, Boel Engarås, Stig B Holmberg, Bengt Gustavsson, P E Jönsson, Per Lindnér, Peter Naredi, G Tidebrant
Cancer - 1994-01-01 -
Hepatic artery occlusion and energy charge in rat liver
tumour.
Per Lindnér, Björn Biber, Bengt Gustavsson, Stig B Holmberg, Peter Naredi, Lars-Olof Hafström
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO - 1994-01-01 -
Regional lymphatic drug exposure following intraperitoneal administration of 5-fluorouracil, carboplatin, and
etoposide.
Per Lindnér, D D Heath, D R Shalinsky, S B Howell, Peter Naredi, Lars-Olof Hafström
Surgical oncology - 1993-01-01 -
The effects of tumour necrosis factor alpha on the vascular bed and blood flow in an experimental rat
hepatoma.
Peter Naredi, Per Lindnér, Stig B Holmberg, U Stenram, A Peterson, Lars-Olof Hafström
International journal of cancer. Journal international du cancer - 1993-01-01 -
The influence of hepatic artery ligation and of vasopressin on liver tumour blood flow in
rats.
Peter Naredi, Per Lindnér, Stig B Holmberg, Rigmor Söderberg, Göran Carlsson, Bengt Gustavsson, Lars Jacobsson, Lars-Olof Hafström
Journal of surgical oncology - 1992-01-01 -
Cytotoxicity of liver macrophages against liver tumours. Influence of betamethasone, indomethacin and
allopurinol.
Stig B Holmberg, Per Lindnér, Peter Naredi, Lars-Olof Hafström
Anticancer research - 1991-01-01